فارسی
(Pre) Clinical Cancer Research Group
(Pre) Clinical Cancer Research Group
Karazmaei Saratan Iranian Pishro Co.
No: 516882




Phase 1-4

Phase 1

Find the
Safest Dose

  • : 20-100
  • : Several Months
  • : Safety & Dosage

Phase 2

Testing of Beneficial Effects &
Undesirable Effects

  • : Several Hundred
  • : Months-2 Years
  • : Efficacy, Side Effects

Phase 3

Monitor
Adverse Reactions

  • : 300-3000
  • : 1-4 Years
  • : Monitor Adverse Reactions

Phase 4

Testing Long Term Safety in
Diverse Patient Population

  • : Several Thousand
  • : Varies
  • : Safety, Efficacy

 

© Copyright 2014-2017 by (Pre) Clinical Cancer Research Group. All rights reserved.